Durham-based Renovion poised for ‘pivotal’ lung transplant trial after closing on $8.1M
Renovian said the funds would support the development and clinical programs associated with their lead therapeutic candidate ARINA-1.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
